JPMorgan Chase & Co. Boosts Stock Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH)
JPMorgan Chase & Co. increased its position in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) by 14.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,129 shares of the company’s stock after buying an additional 1,490 shares during the period. JPMorgan Chase […]
JPMorgan Chase & Co. increased its position in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) by 14.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,129 shares of the company’s stock after buying an additional 1,490 shares during the period. JPMorgan Chase […]
